TOI Short Volume

The Oncology Institute, Inc. (TOI) operates in the Healthcare sector, specifically the Medical - Care Facilities industry, with a market capitalization near $538.9M, listed on NASDAQ, employing roughly 825 people, carrying a beta of 0.41 to the broader market. The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Led by Daniel Virnich, public since 2020-06-04.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-06-30
Short Volume
289.7K
Total Volume
753.4K
Short %
38.44%
30-Day Avg Short %
37.00%

Showing 30 days of FINRA short volume data for The Oncology Institute, Inc..

Learn how short volume is reported and how to read the data →

Frequently asked TOI short volume questions

What is the daily TOI short volume?
As of Jun 30, 2026, The Oncology Institute, Inc. (TOI) short volume is 289.7K shares against 753.4K total reported volume, or 38.44% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is TOI short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does TOI short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.